NPPB and hydrops fetalis: The previous meta-analysis demonstrated the benefit of SGLT2is for HF is consistent across the ranges of ejection fraction or NT-proBNP in trial settings [7], but we still cannot rule out the possibility of residual and unmeasured confounding from other factors.